INSIGHTS ON DRUG DEVELOPMENT
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
Reducing Uncertainty In Early Oral Drug Development
Five recurring decision points in early oral solid dose development carry outsized downstream consequences. AI/ML-driven predictive modeling is reframing how teams manage those decisions under API and timeline constraints.
-
What Are ATMPs And Why Do They Matter?
Delves into the evolution of Advanced Therapy Medicinal Products (ATMPs), exploring their complex development, revolutionary potential in treating diseases, and the intricacies of cell and gene therapies.
-
Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development Workflow
Explore a high-efficiency workflow for isolating and expanding GFP-expressing HEK293 cells that enables stable, bright clones ideal for imaging and tracking to simplify clonal development.
-
The QX700: Advanced Digital PCR System3/26/2026
Advanced digital PCR workflows provide precise, standard-free quantification. Maximize insights from small samples with seven-target multiplexing and automated steps to ensure high-throughput accuracy.
-
Target Product Profile (TPP) Explained7/27/2026
Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.
-
Lipid Nanoparticles For Pulmonary Delivery Of mRNA7/1/2026
Gain insight into how nebulized mRNA lipid nanoparticles show preclinical success in lung delivery, offering fresh momentum for inhaled gene therapies targeting respiratory diseases.
-
Right From The Start: Smarter Developability For Stronger Formulations2/4/2026
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
-
Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs)6/15/2026
ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.
DRUG DEVELOPMENT SOLUTIONS
-
CDMOs, CMOs, and those working on pilot to scale-up operations can benefit from this single-use solution for chromatographic purification that offers easy integration and versatility in scale.
-
Eurofins CDMO Alphora handles small molecule APIs and HPAPIs from IND-enabling through commercialization, with FDA and Health Canada-approved facilities scaling up to 125 kg per batch. Contact them to discuss your program.
-
Examine a customizable imaging workstation designed for complex research needs, combining precision engineering, flexible components, and intuitive software to support advanced applications.
-
The primary characteristic of Containment Isolators is maximizing operator protection: Tema Sinergie Containment Isolator systems have been designed for handling high potent compounds and offer guaranteed very high levels of user protection.
-
Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.